Cite
HARVARD Citation
Moudra, A. et al. (n.d.). 272 NQO1*2 POLYMORPHISM DOES NOT PREDICT OVERALL SURVIVAL IN HIGHER RISK MDS PATIENTS TREATED WITH 5-AZACYTIDINE. Leukemia research. 39 (1), pp. S136-S137. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moudra, A. et al. (n.d.). 272 NQO1*2 POLYMORPHISM DOES NOT PREDICT OVERALL SURVIVAL IN HIGHER RISK MDS PATIENTS TREATED WITH 5-AZACYTIDINE. Leukemia research. 39 (1), pp. S136-S137. [Online].